Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.

Farmer, A; Rodgers, L; Lonergan, M; Shields, Beverley M; Weedon, M. N.; Donnelly, L; Holman, R R; Pearson, E R; Hattersley, Andrew T.

URI

http://hdl.handle.net/11287/595278

Author

Farmer, A

Rodgers, L

Lonergan, M

Shields, Beverley M

Weedon, M. N.

Donnelly, L

Holman, R R

Pearson, E R

Hattersley, Andrew T.

Date

2016-02

Journal

Diabetes care

Type

Journal Article

Publisher

American Diabetes Association

DOI

10.2337/dc15-1194

Rights

Archived with thanks to Diabetes care

Metadata

Show full item record

Abstract

The impact of taking oral glucose-lowering medicines intermittently, rather than as recommended, is unclear. We conducted a retrospective cohort study using community-acquired U.K. clinical data (Clinical Practice Research Database [CPRD] and GoDARTS database) to examine the prevalence of nonadherence to treatment for type 2 diabetes and investigate its potential impact on HbA1c reduction stratified by type of glucose-lowering medication.

Citation

Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database. 2016, 39 (2):258-63 Diabetes Care

Publisher URL

http://care.diabetesjournals.org/cgi/pmidlookup?view=long&pmid=26681714